IBL HealthCare Ltd
Shariah compliantAlmost no debt. No dividend last year, weak results, the price is in a downtrend and priced above its peers.
Working
- Debt is 1% of equity in the latest quarter.
- Operating margin 9% over the last twelve months, above its average of 8% over the last 3 years.
- Short-term assets cover short-term bills 2.7 times in the latest quarter.
To watch
- P/E 20.1 against a sector median of 11.9.
- Rs 1.7bn owed by customers. Collections decide how much of the profit turns into cash.
- Revenue flat on the same quarter last year.
Keep reading IBLHL: business, price trend and value
How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.
Latest results
Quarter: Jul–Sep 2026In the Jul–Sep 2026 quarter, IBLHL's sales was flat at Rs 1.1bn, and profit after tax fell 9% to Rs 64.0mn, from Rs 70.0mn (compared with Jul–Sep 2025).
Earnings per share were Rs 0.65, against Rs 0.81 a year earlier.
At Rs 41.88, IBLHL trades at 19.1 times earnings.
- P/E ratio
- 19.1
- Dividend yield
- 0.0%
- Dividend payout
- 0%
- of earnings
- Return on equity
- 8%
- Net margin
- 5.0%
- last 12 months
- Debt to equity
- 0.01
IBLHL quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Jul–Sep 2026 | Rs 1.1bn | Rs 64.0mn | 5.7% | Rs 0.65 | — |
| Apr–Jun 2026 | Rs 1.3bn | Rs 52.4mn | 4.0% | Rs 0.44 | — |
| Jan–Mar 2026 | Rs 1.2bn | Rs 62.0mn | 5.1% | Rs 0.63 | — |
| Oct–Dec 2025 | Rs 971.0mn | Rs 36.0mn | 3.7% | Rs 0.36 | — |
| Jul–Sep 2025 | Rs 1.1bn | Rs 70.0mn | 6.2% | Rs 0.81 | — |
| Apr–Jun 2025 | Rs 1.2bn | Rs 73.0mn | 6.2% | Rs 0.59 | — |
| Jan–Mar 2025 | Rs 948.0mn | Rs 35.0mn | 3.7% | Rs 0.41 | — |
| Oct–Dec 2024 | Rs 1.1bn | Rs 40.0mn | 3.6% | Rs 0.41 | — |
IBLHL annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Jun 2026 | Rs 4.6bn | Rs 220.4mn | Rs 2.24 | — |
| Year to Jun 2025 | Rs 4.3bn | Rs 208.0mn | Rs 2.11 | — |
| Year to Jun 2024 | Rs 3.6bn | Rs 8.0mn | Rs 0.09 | — |
| Year to Jun 2023 | Rs 4.0bn | Rs 309.0mn | Rs 3.61 | — |
| Year to Jun 2022 | Rs 3.7bn | Rs 303.0mn | Rs 3.53 | Rs 0.76 |
Balance sheet and price
Balance sheet as of Sep 2026- Total assets
- Rs 3.8bn
- Shareholders' equity
- Rs 2.6bn
- Cash & bank
- Rs 191.4mn
- Total debt
- Rs 19.1mn
- Current ratio
- 2.71
- 3-month high
- Rs 52.41
- 3-month low
- Rs 37.71
- 1-month change
- +4.0%
- 3-month change
- -12.1%
Read more about IBLHL
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 924.15P/E 11.1
- AGPAGP LtdRs 149.85P/E 12.7
- BFBIOBF Biosciences LtdRs 123.20P/E 20.0
- CPHLCiti Pharma LtdRs 63.42P/E 15.7
- CWHCCrestwell Healthcare LimitedRs 21.35
- FEROZFerozsons Laboratories LtdRs 337.68P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 315.00P/E 10.4
- HALEONHaleon Pakistan LtdRs 658.64P/E 12.7
- HINOONHighnoon Laboratories LtdRs 956.76P/E 12.1
- HPLHoehcst Pakistan LtdRs 4056.91P/E 10.4
- LIVENLiven Pharma LimitedRs 31.47
- MACTERMacter International LtdRs 244.00P/E 15.3
IBLHL: common questions
What is IBLHL's share price?
IBL HealthCare Ltd (IBLHL) last closed at Rs 41.88 on the Pakistan Stock Exchange.
Does IBLHL pay a dividend?
IBL HealthCare Ltd reported no dividend for the year to Jun 2026.
What were IBLHL's latest results?
In the Jul–Sep 2026 quarter, IBLHL's sales was flat at Rs 1.1bn, and profit after tax fell 9% to Rs 64.0mn, from Rs 70.0mn (compared with Jul–Sep 2025).
What is IBLHL's P/E ratio?
At Rs 41.88, IBLHL trades at 19.1 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.

